being and becoming in the world
It was welcome to read this thoughtful and informed response by Professor Om Prakash. Alas, British psychiatry continues to be in denial about this issue, such that even the review … Continue reading Confronting the Pharmaceutical Shadow in Psychiatry
I submitted two rapid responses to the BMJ in relation to this published letter: Reversing the rate of antidepressant prescribing: I divided my responses in two so that the word … Continue reading The influence of paid opinion leaders on the prescribing of antidepressants in the UK
I have been interested in the responses to this recent BMJ letter: Reversing the rate of antidepressant prescribing . One of the responses was by Dr Torbjörn Waerner. In this … Continue reading “No competing interests”
Confirmed symposia for next year’s Summer Meeting of the British Association for Psychopharmacology [BAP] indicate an increasing defensiveness: BAP ‘symposia’ are generally sponsored by the pharmaceutical industry. BAP meetings continue … Continue reading ‘Preliminary’